Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Cash Flow Statement
Cash Flow Statement
Torrent Pharmaceuticals Ltd
| Mar-2020 | Sep-2020 | Mar-2021 | Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||
| Net Income |
11 866
|
13 976
|
15 263
|
16 963
|
12 259
|
12 649
|
18 472
|
19 422
|
23 520
|
25 790
|
26 730
|
28 850
|
|
| Depreciation & Amortization |
6 544
|
6 574
|
6 578
|
6 648
|
6 622
|
6 472
|
7 066
|
7 806
|
8 083
|
8 113
|
7 949
|
8 049
|
|
| Other Non-Cash Items |
2 218
|
2 968
|
3 351
|
1 681
|
6 878
|
6 358
|
2 307
|
3 697
|
1 857
|
1 287
|
2 011
|
1 341
|
|
| Cash Taxes Paid |
2 840
|
2 030
|
1 755
|
3 105
|
4 210
|
4 260
|
3 981
|
4 151
|
4 981
|
5 671
|
6 028
|
7 398
|
|
| Cash Interest Paid |
4 854
|
4 374
|
3 561
|
3 301
|
2 577
|
2 457
|
3 030
|
3 680
|
3 710
|
3 090
|
2 622
|
2 942
|
|
| Change in Working Capital |
(6 699)
|
(5 429)
|
(5 138)
|
(7 518)
|
(7 729)
|
(6 099)
|
(3 574)
|
(1 644)
|
(800)
|
(1 100)
|
(10 838)
|
(18 838)
|
|
| Cash from Operating Activities |
13 929
N/A
|
18 089
+30%
|
20 054
+11%
|
17 774
-11%
|
18 030
+1%
|
19 380
+7%
|
24 270
+25%
|
29 280
+21%
|
32 661
+12%
|
34 091
+4%
|
25 851
-24%
|
19 401
-25%
|
|
| Investing Cash Flow | |||||||||||||
| Capital Expenditures |
(4 068)
|
(4 388)
|
(3 352)
|
(2 812)
|
(2 026)
|
(3 806)
|
(5 739)
|
(4 479)
|
(4 328)
|
(4 798)
|
(6 119)
|
(5 819)
|
|
| Other Items |
6 054
|
(246)
|
(1 143)
|
2 777
|
59
|
(991)
|
(18 414)
|
(15 654)
|
2 649
|
3 189
|
718
|
(132)
|
|
| Cash from Investing Activities |
1 986
N/A
|
(4 634)
N/A
|
(4 494)
+3%
|
(34)
+99%
|
(1 966)
-5 682%
|
(4 796)
-144%
|
(24 153)
-404%
|
(20 133)
+17%
|
(1 679)
+92%
|
(1 609)
+4%
|
(5 401)
-236%
|
(5 951)
-10%
|
|
| Financing Cash Flow | |||||||||||||
| Net Issuance of Debt |
(3 452)
|
(3 412)
|
(9 563)
|
(10 053)
|
(8 464)
|
(3 644)
|
12 434
|
3 664
|
(13 933)
|
(13 943)
|
(9 527)
|
(5 317)
|
|
| Cash Paid for Dividends |
(7 185)
|
(6 505)
|
(3 385)
|
(5 925)
|
(6 769)
|
(8 119)
|
(8 630)
|
(7 450)
|
(10 153)
|
(9 473)
|
(10 830)
|
(10 830)
|
|
| Other |
(4 854)
|
(4 374)
|
(3 561)
|
(3 301)
|
(2 577)
|
(2 457)
|
(3 030)
|
(3 680)
|
(3 710)
|
(3 090)
|
(2 622)
|
(2 942)
|
|
| Cash from Financing Activities |
(15 490)
N/A
|
(14 290)
+8%
|
(16 508)
-16%
|
(19 278)
-17%
|
(17 811)
+8%
|
(14 221)
+20%
|
774
N/A
|
(7 466)
N/A
|
(27 796)
-272%
|
(26 506)
+5%
|
(22 980)
+13%
|
(19 090)
+17%
|
|
| Change in Cash | |||||||||||||
| Effect of Foreign Exchange Rates |
306
|
376
|
56
|
16
|
5
|
(65)
|
211
|
261
|
81
|
101
|
(87)
|
393
|
|
| Net Change in Cash |
731
N/A
|
(459)
N/A
|
(892)
-94%
|
(1 522)
-71%
|
(1 742)
-14%
|
298
N/A
|
1 101
+270%
|
1 941
+76%
|
3 266
+68%
|
6 076
+86%
|
(2 617)
N/A
|
(5 247)
-101%
|
|
| Free Cash Flow | |||||||||||||
| Free Cash Flow |
9 861
N/A
|
13 701
+39%
|
16 702
+22%
|
14 962
-10%
|
16 004
+7%
|
15 574
-3%
|
18 530
+19%
|
24 800
+34%
|
28 333
+14%
|
29 293
+3%
|
19 732
-33%
|
13 582
-31%
|
|